Fisher Diagnostics 2025-04-09 Health serious FDA
Health · FDA · Recall #FDA-Z-1502-2025
Pacific Hemostasis Thromboplastin-D, 4 ml. Used in performing one-stage prothrombin time… Recall
Issued April 9, 2025 · Fisher Diagnostics
In April 2025, Fisher Diagnostics recalled the Pacific Hemostasis Thromboplastin-D, 4 ml. Used in performing one-stage prothrombin time…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
The incorrect value of the International Sensitivity Index (ISI) is printed on the outer box label.
What you should do
- 1 Stop using Pacific Hemostasis Thromboplastin-D, 4 ml. Used in performing one-stage prothrombin time… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Fisher Diagnostics to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Fisher Diagnostics
- Category
- Health
- Recall date
- April 9, 2025
- Units affected
- Not reported
- Sold at
- US Distribution to: PA and OUS Foreign country of: United Arab Emirates.
- Recall number
- FDA-Z-1502-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Fisher Diagnostics has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.